MED-PHARMEX, INC. is a pharmaceutical preparation manufacturing employer in POMONA, CA. Federal records show 2 OSHA inspections with 2 violations and $795 in penalties. 1 workplace fatality investigation on record. All data sourced from public federal enforcement records.
Data sourced from OSHA, DOL WHD, MSHA, EPA ECHO, NLRB, FMCSA, OFLC, BLS, SAM.gov, CMS, USAspending, CPSC, NHTSA, and the UVA Corporate Prosecution Registry. Last updated: April 29, 2026.
MED-PHARMEX, INC.
2727 THOMPSON RD., POMONA, CA, 91767
Parent: DECHRA (1 locations)
325412 — Top companies in Pharmaceutical Preparation Manufacturing
EIN: 953867924
201 employees
Industry Benchmark
Data Insights
Inspection Breakdown
Peer Comparison
Visa & Labor Certification (OFLC)
Need API access, CSV upload, or PDF reports? Upgrade to Paid for $79/mo.
Inspection History
No inspection records found.
Related Searches
The FastDOL Report
Weekly workplace compliance news. Free.
Data aggregated from public federal enforcement and program records (OSHA, WHD, MSHA, EPA, NLRB, FMCSA, OFLC, BLS, SAM.gov, CMS, USAspending, CPSC, NHTSA) plus the UVA Corporate Prosecution Registry. Employer profiles matched by name and location — matching errors may occur. Risk scores computed by FastDOL, not official government assessments. OSHA citations typically appear 3-8 months after the inspection, so very recent enforcement actions may not yet be reflected. Data provided as-is. Report a data error.
Frequently Asked Questions
- What is MED-PHARMEX, INC.'s OSHA violation history?
- MED-PHARMEX, INC. has 2 OSHA inspections on record with 2 violations and $795 in total penalties.
- How does MED-PHARMEX, INC.'s safety record compare to its industry?
- MED-PHARMEX, INC. operates in the pharmaceutical preparation manufacturing industry. The industry average Total Recordable Incident Rate (TRIR) is 1.4. MED-PHARMEX, INC.'s self-reported DART rate is 6.61 compared to an industry average of 0.9.
- Has MED-PHARMEX, INC. had any workplace fatalities?
- Yes. Federal records show 1 fatality investigation involving MED-PHARMEX, INC..